Carbon Monoxide Releasing Molecules Blunt Placental Ischemia-Induced Hypertension

American Journal of Hypertension

Volumn 30, Issue 9, 2017, Pages 931-937

  George, Eric M ^a,b   Cockrell, Kathy ^a   Arany, Marietta ^a   Stec, David E ^a   Rimoldi, John M ^c   Gadepalli, Rama S V ^c   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

blood pressure; carbon monoxide; heme oxygenase 1; hypertension; preeclampsia; pregnancy

Indexed keywords

CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 3; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FMS LIKE TYROSINE KINASE 1; HEME OXYGENASE 1; ISOFLURANE; LIQUID NITROGEN; PHOSPHATE BUFFERED SALINE; PLACENTA PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; ANTIHYPERTENSIVE AGENT; FLT1 PROTEIN, RAT; ORGANOMETALLIC COMPOUND; TRICARBONYLCHLORO(GLYCINATO)RUTHENIUM(II); VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ABDOMINAL AORTA; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BICINCHONINIC ACID ASSAY; BLOOD PRESSURE; BODY WEIGHT; CATHETERIZATION; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; GLOMERULUS FILTRATION RATE; ISCHEMIA; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; NONHUMAN; PLACENTAL ISCHEMIA; PREECLAMPSIA; RAT; RENAL ARTERY; VASODILATATION; ANIMAL; BLOOD; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GESTATIONAL AGE; KIDNEY; KIDNEY ARTERY; METABOLISM; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARBON MONOXIDE; DISEASE MODELS, ANIMAL; FEMALE; GESTATIONAL AGE; GLOMERULAR FILTRATION RATE; ISCHEMIA; KIDNEY; ORGANOMETALLIC COMPOUNDS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RATS, SPRAGUE-DAWLEY; RENAL ARTERY; RENAL PLASMA FLOW; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASODILATION;

EID: 85030638782     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpx070     Document Type: Article

References (29)

1. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122:1122–1131.
2. Khong Y, Brosens I. Defective deep placentation. Best Pract Res Clin Obstet Gynaecol 2011; 25:301–311.
3. Clark DE, Smith SK, He Y, Day KA, Licence DR, Corps AN, Lammoglia R, Charnock-Jones DS. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998; 59:1540–1548.
4. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649–658.
5. Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J Cell Mol Med 2010; 14:528–552.
6. Bergmann A, Ahmad S, Cudmore M, Gruber AD, Wittschen P, Lindenmaier W, Christofori G, Gross V, Gonzalves ACh, Gröne HJ, Ahmed A, Weich HA. Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med 2010; 14:1857–1867.
7. George EM, Arany M, Cockrell K, Storm MV, Stec DE, Granger JP. Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol 2011; 301:R1495–R1500.
8. Morris KA, Golding JF, Blesing C, Evans DG, Ferner RE, Foweraker K, Halliday D, Jena R, McBain C, McCabe MG, Swampillai A, Warner N, Wilson S, Parry A, Afridi SK; UK NF2 research group. Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort. J Neurooncol 2017; 131:117–124.
9. Józkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, Dulak J. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid Redox Signal 2003; 5:155–162.
10. Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 2005; 57:585–630.
11. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007; 115:1789–1797.
12. George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 2011; 57:941–948.
13. George EM, Stout JM, Stec DE, Granger JP. Heme oxygenase induction attenuates TNF-α-induced hypertension in pregnant rodents. Front Pharmacol 2015; 6:165.
14. George EM, Colson D, Dixon J, Palei AC, Granger JP. Heme oxygenase-1 attenuates hypoxia-induced sFlt-1 and oxidative stress in placental villi through its metabolic products CO and bilirubin. Int J Hypertens 2012; 2012:486053.
15. Alexander BT, Kassab SE, Miller MT, Abram SR, Reckelhoff JF, Bennett WA, Granger JP. Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide. Hypertension 2001; 37:1191–1195.
16. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, Motterlini R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003; 93:e2–e8.
17. Schock-Kusch D, Xie Q, Shulhevich Y, Hesser J, Stsepankou D, Sadick M, Koenig S, Hoecklin F, Pill J, Gretz N. Transcutaneous assessment of renal function in conscious rats with a device for measuring FITC-sinistrin disappearance curves. Kidney Int 2011; 79:1254–1258.
18. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 2007; 50:1142–1147.
19. Turner JA. Diagnosis and management of pre-eclampsia: an update. Int J Womens Health 2010; 2:327–337.
20. Stojanovska V, Scherjon SA, Plösch T. Preeclampsia as modulator of offspring health. Biol Reprod 2016; 94:53.
21. Bokslag A, van Weissenbruch M, Mol BW, de Groot CJ. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev 2016; 102:47–50.
22. Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I, Bussolati B, St John J. Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 2000; 6:391–409.
23. Zenclussen AC, Sollwedel A, Bertoja AZ, Gerlof K, Zenclussen ML, Woiciechowsky C, Volk HD. Heme oxygenase as a therapeutic target in immunological pregnancy complications. Int Immunopharmacol 2005; 5:41–51.
24. Sabaawy HE, Zhang F, Nguyen X, ElHosseiny A, Nasjletti A, Schwartzman M, Dennery P, Kappas A, Abraham NG. Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats. Hypertension 2001; 38:210–215.
25. Yang L, Quan S, Nasjletti A, Laniado-Schwartzman M, Abraham NG. Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure. Hypertension 2004; 43:1221–1226.
26. Botros FT, Schwartzman ML, Stier CT Jr, Goodman AI, Abraham NG. Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int 2005; 68:2745–2755.
27. Sela S, Natanson-Yaron S, Zcharia E, Vlodavsky I, Yagel S, Keshet E. Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase. Circ Res 2011; 108:1063–1070.
28. Alexander BT, Rinewalt AN, Cockrell KL, Massey MB, Bennett WA, Granger JP. Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 2001; 37:485–489.
29. Ryan MJ, Jernigan NL, Drummond HA, McLemore GR Jr, Rimoldi JM, Poreddy SR, Gadepalli RS, Stec DE. Renal vascular responses to CORM-A1 in the mouse. Pharmacol Res 2006; 54:24–29.